These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22247121)

  • 1. Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study.
    Kristensen K; Hjuler T; Ravn H; Simões EA; Stensballe LG
    Clin Infect Dis; 2012 Mar; 54(6):810-7. PubMed ID: 22247121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.
    Bradley JP; Bacharier LB; Bonfiglio J; Schechtman KB; Strunk R; Storch G; Castro M
    Pediatrics; 2005 Jan; 115(1):e7-14. PubMed ID: 15629968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome and hospitalizations due to respiratory syncytial virus: a population-based study.
    Zachariah P; Ruttenber M; Simões EA
    J Pediatr; 2012 May; 160(5):827-31.e1. PubMed ID: 22177993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The causal direction in the association between respiratory syncytial virus hospitalization and asthma.
    Stensballe LG; Simonsen JB; Thomsen SF; Larsen AM; Lysdal SH; Aaby P; Kyvik KO; Skytthe A; Backer V; Bisgaard H
    J Allergy Clin Immunol; 2009 Jan; 123(1):131-137.e1. PubMed ID: 19130934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for respiratory syncytial virus hospitalisation in children with heart disease.
    Kristensen K; Stensballe LG; Bjerre J; Roth D; Fisker N; Kongstad T; Svendsen AL; Nielsen BW
    Arch Dis Child; 2009 Oct; 94(10):785-9. PubMed ID: 19541682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory syncytial virus infection--risk factors for hospital admission: a case-control study.
    Nielsen HE; Siersma V; Andersen S; Gahrn-Hansen B; Mordhorst CH; Nørgaard-Pedersen B; Røder B; Sørensen TL; Temme R; Vestergaard BF
    Acta Paediatr; 2003 Nov; 92(11):1314-21. PubMed ID: 14696852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Hospitalization for Respiratory Syncytial Virus Infection: A Population-based Cohort Study of Danish Children.
    Haerskjold A; Kristensen K; Kamper-Jørgensen M; Nybo Andersen AM; Ravn H; Graff Stensballe L
    Pediatr Infect Dis J; 2016 Jan; 35(1):61-5. PubMed ID: 26398871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus infection in elderly and high-risk adults.
    Falsey AR; Hennessey PA; Formica MA; Cox C; Walsh EE
    N Engl J Med; 2005 Apr; 352(17):1749-59. PubMed ID: 15858184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.
    Pedraz C; Carbonell-Estrany X; Figueras-Aloy J; Quero J;
    Pediatr Infect Dis J; 2003 Sep; 22(9):823-7. PubMed ID: 14506376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort study.
    Yi H; Lanctôt KL; Bont L; Bloemers BL; Weijerman M; Broers C; Li A; Kiss A; Mitchell I; Paes B;
    Pediatrics; 2014 Jun; 133(6):1031-7. PubMed ID: 24799541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002.
    Henckel E; Luthander J; Berggren E; Kapadia H; Naver L; Norman M; Bennet R; Eriksson M
    Pediatr Infect Dis J; 2004 Jan; 23(1):27-31. PubMed ID: 14743042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study.
    Thomsen SF; van der Sluis S; Stensballe LG; Posthuma D; Skytthe A; Kyvik KO; Duffy DL; Backer V; Bisgaard H
    Am J Respir Crit Care Med; 2009 Jun; 179(12):1091-7. PubMed ID: 19286626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course.
    Wilkesmann A; Ammann RA; Schildgen O; Eis-Hübinger AM; Müller A; Seidenberg J; Stephan V; Rieger C; Herting E; Wygold T; Hornschuh F; Groothuis JR; Simon A;
    Pediatr Infect Dis J; 2007 Jun; 26(6):485-91. PubMed ID: 17529864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants.
    Singleton R; Dooley L; Bruden D; Raelson S; Butler JC
    Pediatr Infect Dis J; 2003 Jun; 22(6):540-5. PubMed ID: 12799511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study.
    Fryzek JP; Martone WJ; Groothuis JR
    Adv Ther; 2011 Mar; 28(3):195-201. PubMed ID: 21327753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial infection: a risk factor for a complicated course in children with respiratory syncytial virus infection--results from a prospective multicenter German surveillance study.
    Simon A; Müller A; Khurana K; Engelhart S; Exner M; Schildgen O; Eis-Hübinger AM; Kamin W; Schaible T; Wadas K; Ammann RA; Wilkesmann A;
    Int J Hyg Environ Health; 2008 Jul; 211(3-4):241-50. PubMed ID: 17869579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls.
    Sigurs N; Bjarnason R; Sigurbergsson F; Kjellman B; Björkstén B
    Pediatrics; 1995 Apr; 95(4):500-5. PubMed ID: 7700748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study.
    Stensballe LG; Hjuler T; Andersen A; Kaltoft M; Ravn H; Aaby P; Simoes EA
    Clin Infect Dis; 2008 Apr; 46(8):1165-71. PubMed ID: 18444851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.